Medical Devices Startups

Trinzz builds data infrastructure and quality systems for regulated medical AI, focusing on reliability frameworks, expert validation, and governance standards that enable hospital deployment. The company transforms complex biomedical imaging data into deployment-ready training datasets with measurable reliability, calibration integrity, and audit-grade traceability for precision medicine and diagnostics teams.

1 investor

TrioMed develops portable peritoneal dialysis systems for patients requiring renal replacement therapy at home or while traveling.

1 investor

Trisol Medical develops a transcatheter tricuspid valve replacement device, using a nitinol frame with a dome-shaped leaflet, to treat severe tricuspid regurgitation while preserving right ventricle function. The device targets patients with tricuspid regurgitation who cannot undergo surgical treatment, in the cardiovascular medical device sector.

1 investor

1 investor

Trivitron builds clinically validated AI tools for radiology and laboratory diagnostics, including image enhancement and predictive analytics that integrate into existing workflows. The solutions support faster interpretation, reduce repeat work, and improve consistency for clinical teams without disrupting established processes.

1 investor

Truelli makes a menstrual pad that analyzes menstrual blood to detect health markers, paired with a companion app for scanning and reviewing results at home. The product screens for conditions such as anemia, fertility and perimenopause indicators, STIs, cancer, diabetes, and cardiovascular issues, targeting women's health.

1 investor

TruMed Systems provides inventory management solutions for vaccine storage and medication handling in healthcare facilities, serving clinics, health systems, and public healthcare providers across the United States. The company operates AccuVax and AccuShelf product lines that automate inventory control, enhance patient safety, and optimize clinical workflows.

1 investor

TTP (formerly The Technology Partnership) is a technology and product development company that works on projects across deep tech, life sciences, and health tech for international clients and start-ups. Founded in 1987, it operates a campus-based team of over 550 people delivering product development and engineering work.

1 investor

Tulyp Medical develops the Tulyp System, an investigational pressure-controlled perfusion device with a microaxial pump cannula designed to restore blood flow to the leg in patients on femoral arterial support (VA-ECMO, IABP, pVAD) who are at risk of acute limb ischemia. The device is in preclinical and early first-in-human testing and is not yet FDA cleared or approved.

1 investor

Turbo Coating operates the Surface Solutions Division, which provides coating and surface treatment services. The division serves industrial clients requiring specialized surface solutions.

1 investor

TurningMode develops medical technologies for healthcare providers including smart illumination systems, patient ventilation solutions, and sterilization technology. The company aims to improve clinical workflows and patient care outcomes for physicians, nurses, and caregivers.

1 investor

Roche develops diagnostics and pharmaceutical medicines to address major healthcare challenges and improve patient outcomes across prevention, treatment, and cure.

1 investor

Twig Fertility provides guidance, service, technology, and support to couples navigating the fertility treatment journey. The company aims to improve the patient experience within fertility clinics by offering comprehensive hand-holding and education throughout the process.

1 investor

TwinStrand develops Duplex Sequencing technology, a genomic platform for improving accuracy in clinical medicine and life sciences research applications. The company works with partners to translate genomic research into products for human health and scientific discovery.

1 investor

Twilight develops injectable precision immunotherapies to train the body's immune system to treat chronic diseases at scale. The company targets conditions that existing therapies inadequately address, with a focus on neurological and immunological diseases.

1 investor

Tympanogen develops Perf-Fix, a gel patch system for nonsurgical eardrum (tympanic membrane) repair that replaces traditional tympanoplasty with a clinic-based procedure. The product is aimed at ENT surgeons and clinicians for outpatient otologic care and is currently in development.

1 investor

Type One Style is a UK-based direct-to-consumer company that designs and manufactures diabetes care products and accessories, with a focus on mental health support and community for people with diabetes. The company produces all goods in-house and sells globally, combining product innovation with content and community building.

1 investor

Tyris Therapeutics develops non-viral gene therapies using a proprietary DNA format (oDNA™) to treat rare and prevalent genetic diseases. The company aims to provide safer, controllable treatments that can accommodate genes of any size, with the ability to adjust dosing and allow for retreatment.

1 investor

Ubique Biotech develops AI-designed synthetic reagents (antigen and antibody based) for precision diagnostics used in formats such as ELISA and rapid point-of-care tests. Founded in 2022, it focuses on affordable, scalable disease detection and screening without extensive laboratory infrastructure.

1 investor

UCLA Health is a major academic health system providing patient care across five hospitals and 290 clinics in Southern California and the Central Coast, alongside research and medical education. The organization conducts pioneering research in oncology, transplantation, neurosurgery, and other specialties, having contributed to the development of numerous FDA-approved treatments.

1 investor

Vizgen develops high-throughput spatial profiling technologies, including MERFISH-based spatial genomics and spatial proteomics tools for life science research and precision oncology. The company (which merged with Ultivue) serves biopharma and research customers with instruments and reagents for spatial biology.

1 investor

Ultra CHILL is a cold therapy and compression sleeve for ankle recovery that combines a flexible gel with 360° coverage in a slip-on design. Designed for post-workout recovery, injury management, and everyday ankle soreness without the mess or inconvenience of traditional ice packs.

1 investor

Uman Sense is a medical technology company and a spin-off from Lund University that develops Stroke Alarm, a wearable device that monitors for stroke symptoms around the clock and notifies designated contacts by SMS when a stroke is suspected. The product aims to help stroke patients receive timely treatment.

1 investor

Ultrasonic Medical Mapping develops ultrasound-based medical mapping technology aimed at detecting pancreatic cancer at an early stage. The company positions its approach as a lower-cost diagnostic method in the medical device and cancer detection space.

1 investor